Cargando…

Intermittent screening and treatment with dihydroartemisinin-piperaquine and intermittent preventive therapy with sulfadoxine-pyrimethamine have similar effects on malaria antibody in pregnant Malawian women

In a randomised trial comparing intermittent screening and treatment (IST) with dihydroartemisinin-piperaquine (DP) and intermittent preventive therapy against malaria in pregnancy (IPT) with sulfadoxine-pyrimethamine (SP) in Malawi, the impacts of IST-DP and IPT-SP on the development and maintenanc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teo, Andrew, Randall, Louise M., Madanitsa, Mwayiwawo, Mwapasa, Victor, Phiri, Linda Kalilani, Khairallah, Carole, Buffet, Christelle, Karahalios, Amalia, Narum, David L., Kuile, Feiko O. Ter, Rogerson, Stephen J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536723/ https://www.ncbi.nlm.nih.gov/pubmed/31133672 http://dx.doi.org/10.1038/s41598-019-44340-x

Ejemplares similares

Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlled Trial
por: Madanitsa, Mwayiwawo, et al.
Publicado: (2016)

Effect of dihydroartemisinin/piperaquine for malaria intermittent preventive treatment on dolutegravir exposure in pregnant women living with HIV
por: Banda, Clifford G., et al.
Publicado: (2022)

Impact of Dolutegravir-Based Antiretroviral Therapy on Piperaquine Exposure following Dihydroartemisinin-Piperaquine Intermittent Preventive Treatment of Malaria in Pregnant Women Living with HIV
por: Banda, Clifford G., et al.
Publicado: (2022)

Randomized Trial of Piperaquine with Sulfadoxine-Pyrimethamine or Dihydroartemisinin for Malaria Intermittent Preventive Treatment in Children
por: Cisse, Badara, et al.
Publicado: (2009)

Effect of monthly intermittent preventive treatment with dihydroartemisinin–piperaquine with and without azithromycin versus monthly sulfadoxine–pyrimethamine on adverse pregnancy outcomes in Africa: a double-blind randomised, partly placebo-controlled trial
por: Madanitsa, Mwayiwawo, et al.
Publicado: (2023)

Provider and user acceptability of intermittent screening and treatment for the control of malaria in pregnancy in Malawi
por: Almond, Deborah, et al.
Publicado: (2016)

Intermittent screening and treatment with artemisinin-combination therapy versus intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria in pregnancy: a systematic review and individual participant data meta-analysis of randomised clinical trials
por: Gutman, Julie R, et al.
Publicado: (2021)

Impact of intermittent preventive treatment of malaria in pregnancy with dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine on the incidence of malaria in infancy: a randomized controlled trial
por: Kakuru, Abel, et al.
Publicado: (2020)

Sequential disruptions to inflammatory and angiogenic pathways and risk of spontaneous preterm birth in Malawian women
por: Weckman, Andrea M., et al.
Publicado: (2023)

Dihydroartemisinin–piperaquine holds promise as an option for malaria prevention in pregnancy
por: Hill, Jenny, et al.
Publicado: (2016)

Independent Lineages of Highly Sulfadoxine-Resistant Plasmodium falciparum Haplotypes, Eastern Africa
por: Taylor, Steve M., et al.
Publicado: (2014)

Neurocognitive outcomes in Malawian children exposed to malaria during pregnancy: An observational birth cohort study
por: Weckman, Andrea M., et al.
Publicado: (2021)

Intermittent preventive treatment: efficacy and safety of sulfadoxine-pyrimethamine and sulfadoxine-pyrimethamine plus piperaquine regimens in schoolchildren of the Democratic Republic of Congo: a study protocol for a randomized controlled trial
por: Doua, Joachim Yorokpa, et al.
Publicado: (2013)

Changing the policy for intermittent preventive treatment with sulfadoxine–pyrimethamine during pregnancy in Malawi
por: Mwendera, Chikondi A., et al.
Publicado: (2017)

Sulfadoxine/Pyrimethamine Intermittent Preventive Treatment for Malaria during Pregnancy
por: Deloron, Philippe, et al.
Publicado: (2010)

Piperaquine Pharmacokinetics during Intermittent Preventive Treatment for Malaria in Pregnancy
por: Chotsiri, Palang, et al.
Publicado: (2021)

Overall, anti-malarial, and non-malarial effect of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine on birthweight: a mediation analysis
por: Roh, Michelle E, et al.
Publicado: (2020)

Intermittent presumptive treatment in pregnancy with sulfadoxine–pyrimethamine: a counter perspective
por: Nosten, Francois, et al.
Publicado: (2015)

Intermittent Preventive Treatment with Sulfadoxine–Pyrimethamine: More than Just an Antimalarial?
por: Gutman, Julie, et al.
Publicado: (2017)

Detection of Falsified Antimalarial Sulfadoxine-Pyrimethamine and Dihydroartemisinin-Piperaquine Drugs Using a Low-Cost Handheld Near-Infrared Spectrometer
por: Yabré, Moussa, et al.
Publicado: (2022)

Efficacy and safety of intermittent preventive treatment and intermittent screening and treatment versus single screening and treatment with dihydroartemisinin–piperaquine for the control of malaria in pregnancy in Indonesia: a cluster-randomised, open-label, superiority trial
por: Ahmed, Rukhsana, et al.
Publicado: (2019)

Cost-effectiveness of intermittent preventive treatment with dihydroartemisinin–piperaquine for malaria during pregnancy: an analysis using efficacy results from Uganda and Kenya, and pooled data
por: Fernandes, Silke, et al.
Publicado: (2020)

Pharmacokinetics of Piperaquine and Safety Profile of Dihydroartemisinin-Piperaquine Coadministered with Antiretroviral Therapy in Malaria-Uninfected HIV-Positive Malawian Adults
por: Banda, Clifford G., et al.
Publicado: (2018)

Adherence to community versus facility-based delivery of monthly malaria chemoprevention with dihydroartemisinin-piperaquine for the post-discharge management of severe anemia in Malawian children: A cluster randomized trial
por: Nkosi-Gondwe, Thandile, et al.
Publicado: (2021)

Safety and efficacy of intermittent presumptive treatment with sulfadoxine-pyrimethamine using rapid diagnostic test screening and treatment with dihydroartemisinin-piperaquine at the first antenatal care visit (IPTp-SP+): study protocol for a randomized controlled trial
por: Kabuya, Jean-Bertin Bukasa, et al.
Publicado: (2021)

Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial
por: Taylor, Steve M., et al.
Publicado: (2022)

Marked Reduction in Prevalence of Malaria Parasitemia and Anemia in HIV-Infected Pregnant Women Taking Cotrimoxazole With Or Without Sulfadoxine-Pyrimethamine Intermittent Preventive Therapy during Pregnancy in Malawi
por: Kapito-Tembo, Atupele, et al.
Publicado: (2011)

Economic Evaluation of an Alternative Drug to Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy
por: Sicuri, Elisa, et al.
Publicado: (2015)

The challenge of using intermittent preventive therapy with sulfadoxine/pyrimethamine among pregnant women in Uganda
por: Wanzira, Humphrey, et al.
Publicado: (2016)

Pharmacokinetics of Sulfadoxine and Pyrimethamine for Intermittent Preventive Treatment of Malaria During Pregnancy and After Delivery
por: de Kock, M, et al.
Publicado: (2017)

Safety, tolerability, and efficacy of repeated doses of dihydroartemisinin-piperaquine for prevention and treatment of malaria: a systematic review and meta-analysis
por: Gutman, Julie, et al.
Publicado: (2017)

Erratum: Pharmacokinetics of Sulfadoxine and Pyrimethamine for Intermittent Preventive Treatment of Malaria During Pregnancy and After Delivery
Publicado: (2020)

Effectiveness of Sulfadoxine–Pyrimethamine for Intermittent Preventive Treatment of Malaria and Adverse Birth Outcomes in Pregnant Women
por: Mlugu, Eulambius M., et al.
Publicado: (2020)

Erratum: Pharmacokinetics of Sulfadoxine and Pyrimethamine for Intermittent Preventive Treatment of Malaria During Pregnancy and After Delivery
por: de Kock, M., et al.
Publicado: (2020)

Corrigendum: Pharmacokinetics of Sulfadoxine and Pyrimethamine for Intermittent Preventive Treatment of Malaria During Pregnancy and After Delivery
Publicado: (2021)

Dihydroartemisinin-piperaquine or sulphadoxine-pyrimethamine for the chemoprevention of malaria in children with sickle cell anaemia in eastern and southern Africa (CHEMCHA): a protocol for a multi-centre, two-arm, double-blind, randomised, placebo-controlled superiority trial
por: Nkosi-Gondwe, Thandile, et al.
Publicado: (2023)

Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model
por: Walker, Patrick G. T., et al.
Publicado: (2017)

The risk of malaria in Ghanaian infants born to women managed in pregnancy with intermittent screening and treatment for malaria or intermittent preventive treatment with sulfadoxine/pyrimethamine
por: Awine, Timothy, et al.
Publicado: (2016)

User and Provider Acceptability of Intermittent Screening and Treatment and Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine to Prevent Malaria in Pregnancy in Western Kenya
por: Hill, Jenny, et al.
Publicado: (2016)

Follow-up Survey of Children Who Received Sulfadoxine-Pyrimethamine for Intermittent Preventive Antimalarial Treatment in Infants
por: Kobbe, Robin, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4jqjl6q01h7t9dqmsmlepmtbbm